Secret claims substantiated
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble product claims for Secret Clinical Strength are fully substantiated, the National Advertising Division of the Council of Better Business Bureaus determines July 23. NAD reviewed product and labeling claims including "Clinical Strength," "delivers ... clinically-proven wetness protection," and "Doctor-endorsed Secret Clinical Strength gives you prescription strength wetness protection without a prescription." NAD examined evidence including two clinical trial studies conducted by the firm to support performance claims and two studies involving consumer testing and a survey of 200 primary care physicians and dermatologists...
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.